serial,sid,uuid,token,uri,created,completed,changed,in_draft,current_page,remote_addr,uid,langcode,webform_id,entity_type,entity_id,locked,sticky,notes,first_name,last_name,email,phone,affiliation_presenter,abstract_title,first_name_author1,last_name_author1,affiliation_author1,additional_authors_list,topic_classification,your_abstract_submission,upload_abstract_1,special_characters_included_,abstract_review_status,poster_uploaded,upload_poster
1,1,4dfec5cf-2ec8-4ba6-9c77-6af9f947f8dd,dccefsSjz7odx3YlyzIqYBIj30F1Zn8-OxyEvxJzAQ0,/dctd/lungsporemeeting/abstracts,1700869510,1702388215,1732491910,,,124.183.43.8,809,en,lung_spore_investigator_abstract,node,1171,,,,John,McCartney,example@example.com,098-765-4321,Oratione,"Quae cum dixisset, finem ille. Quamquam non negatis nos intellegere quid sit voluptas, sed quid ille dicat. Progredientibus autem aetatibus sensim tardeve potius quasi nosmet ipsos cognoscimus. Gloriosa ostentatio in constituendo summo bono. Qui-vere falsone, quaerere mittimus-dicitur oculis se privasse; Duarum enim vitarum nobis erunt instituta capienda. Comprehensum, quod cognitum non habet? Qui enim existimabit posse se miserum esse beatus non erit. Causa autem fuit huc veniendi ut quosdam hinc libros promerem. Nunc omni virtuti vitium contrario nomine opponitur.",George,Lennon,Loremipsum,"[{ first_name: George, last_name: Starr, affiliation: Dixisset }, { first_name: Paul, last_name: Lennon, affiliation: Oratione }, { first_name: Ringo, last_name: Harrison, affiliation: Loremipsum }]","Session 1: Oncogene-driven lung cancers and resistance to targeted therapies,Session 3: Immuno-oncology,Session 6: Cancer Biology",,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_abstract_1_9.docx,1,"Not Approved",Yes,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_poster.jpg
2,2,4eb50abb-fa2f-4a67-8cd9-616e5ff86c69,QwQu4xa9sB17fym6G1HT8b0hu0fKfkNBrsq3TVd0qgw,/dctd/lungsporemeeting/abstracts,1700869510,1720358644,1732491910,,,208.88.97.26,661,en,lung_spore_investigator_abstract,node,1171,,,,Paul,Harrison,example@example.com,098-765-4321,Dixisset,"Huius, Lyco, oratione locuples, rebus ipsis ielunior. Duo Reges: constructio interrete. Sed haec in pueris; Sed utrum hortandus es nobis, Luci, inquit, an etiam tua sponte propensus es? Sapiens autem semper beatus est et est aliquando in dolore; Immo videri fortasse. Paulum, cum regem Persem captum adduceret, eodem flumine invectio? Et ille ridens: Video, inquit, quid agas;",John,McCartney,Loremipsum,"[{ first_name: George, last_name: Lennon, affiliation: Dixisset }, { first_name: Ringo, last_name: Starr, affiliation: Oratione }, { first_name: George, last_name: Starr, affiliation: Oratione }]","Session 1: Oncogene-driven lung cancers and resistance to targeted therapies,Session 3: Immuno-oncology,Session 2:  Health Disparities in Lung Cancer",,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_abstract_1_21.doc,1,"Approved to be a Speaker",Yes,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_poster.jpg
3,3,7dcec83b-647a-4bc7-a171-159e04000f4a,5j1sTsfEdUD1MlzkvDzDD62H8MybhaxP5Ftuvh1j18Y,/dctd/lungsporemeeting/abstracts,1700869511,1710287229,1732491911,,,175.69.208.107,588,en,lung_spore_investigator_abstract,node,1171,,,,John,McCartney,random@random.com,098-765-4321,Dixisset,"Huius, Lyco, oratione locuples, rebus ipsis ielunior. Duo Reges: constructio interrete. Sed haec in pueris; Sed utrum hortandus es nobis, Luci, inquit, an etiam tua sponte propensus es? Sapiens autem semper beatus est et est aliquando in dolore; Immo videri fortasse. Paulum, cum regem Persem captum adduceret, eodem flumine invectio? Et ille ridens: Video, inquit, quid agas;",Paul,Harrison,Loremipsum,"[{ first_name: Ringo, last_name: Harrison, affiliation: Loremipsum }, { first_name: George, last_name: McCartney, affiliation: Oratione }, { first_name: Paul, last_name: Lennon, affiliation: Dixisset }]","Session 5: Early Detection and Screening,Session 3: Immuno-oncology,Session 1: Oncogene-driven lung cancers and resistance to targeted therapies",,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_abstract_1_22.doc,1,"Approved to be a Poster Presenter",Yes,https://events.cancer.gov/sites/default/files/webform/lung_spore_investigator_abstract/_sid_/upload_poster.jpg